Intrinsic Value

Heron Therapeutics, Inc. (HRTX)


+0.21 (+5.24%)
Enterprise Value -
Net Debt 63.38
Equity Value -
Shares Outstanding 98.47
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt